Living Donor Clinical Parameter Can Predict Renal Function in Kidney Recipients.

被引：0
|
作者：
Bilovsky-Muniz, T. [1 ]
Tavakol, M. [1 ]
Lee, B. [1 ]
Tomlanovich, S. [1 ]
Roberts, J. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01616
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A299
引用
收藏
页码：485 / 485
页数：1
相关论文
共 50 条
  • [21] One DRB1 matched living unrelated donor receipients demonstrate better renal function as compared to unmatched living unrelated donor recipients and/or matched cadaveric donor recipients.
    Cirocco, Robert E.
    Gomez, Carmen
    Goldsmith, Lottie
    Ruiz, Phil
    Burke, George
    Tzakis, Andreas
    HUMAN IMMUNOLOGY, 2007, 68 : S93 - S93
  • [22] Risk of Acute Rejection Among ABO Incompatible Living Donor Kidney Recipients.
    MacLennan, P.
    Kumar, V.
    Reed, R.
    Mompoint-Williams, D.
    Stegner, K.
    Locke, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 604 - 604
  • [23] Living Donor Renal Transplantation Overcomes Racial Disparities in African American Recipients.
    Saad, Ismail R.
    Modlin, Charles
    Alster, Joan M.
    Tiong, Ho Yee
    Mastroianni, Barbara
    Savas, Kathy
    Flechner, Stuart M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 705 - 706
  • [24] Impact of Belatacept Conversion on Renal Function and Donor Specific Antibodies in Renal Transplant Recipients.
    Brown, E. R.
    Cunningham, K.
    Paplaczyk, K.
    Dagostino, C.
    Kane, C.
    Shetty, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 710 - 711
  • [25] Impact of Remote Ischemic Preconditioning Conducted in Living Kidney Donors on Renal Function in Donors and Recipients Following Living Donor Kidney Transplantation: A Randomized Clinical Trial
    Bang, Ji-Yeon
    Kim, Sae-Gyeol
    Oh, Jimi
    Kim, Seon-Ok
    Go, Yon-Ji
    Hwang, Gyu-Sam
    Song, Jun-Gol
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [26] Chronic Kidney Disease Stage Progression Comparing Living Donor and Deceased Donor Liver Transplant Recipients.
    Ahmed, E.
    Yankol, Y.
    Rizzari, M.
    Fernandez, L.
    Leverson, G.
    Foley, D.
    Mezrich, J.
    Kanmaz, T.
    D'Alessandro, A.
    Acarli, K.
    Kalayoglu, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 761 - 761
  • [27] Chronic Kidney Disease Stage Progression Comparing Living Donor and Deceased Donor Liver Transplant Recipients.
    Ahmed, E.
    Yankol, Y.
    Rizzari, M.
    Fernandez, L.
    Leverson, G.
    Foley, D.
    Mezrich, J.
    Kanmaz, T.
    D'Alessandro, A.
    Acarli, K.
    Kalayoglu, M.
    TRANSPLANTATION, 2014, 98 : 761 - 761
  • [28] Effects of Three Immunosuppressive Regimens On Renal Function in Kidney Transplant Recipients.
    Ferreira, A.
    Felipe, C.
    Ueno, P.
    Hannun, P.
    Gusukuma, L.
    Cristelli, M.
    Sandes-Freitas, T.
    Tedesco, H.
    Franco, M.
    Medina-Pestana, J.
    TRANSPLANTATION, 2014, 98 : 540 - 540
  • [29] Impact of Case Scheduling on Hospital Cost and Length of Stay in Living Donor Kidney Recipients.
    Yu, J.
    Dageforde, L. A.
    Doyle, M. B.
    Khan, A. S.
    Chapman, W. C.
    Lin, Y.
    Shenoy, S.
    Alhamad, T.
    Horwedel, T. A.
    Wellen, J. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1039 - 1039
  • [30] Predicting Urinary Tract Infections Requiring Hospitalization in Living Donor Kidney Transplant Recipients.
    Dinh, A.
    Copeland, T.
    Adey, D.
    Ku, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 571 - 571
12345